Stockholders’ Equity (Details)						1 Months Ended	6 Months Ended
	Jun. 16, 2022 USD ($) shares	Jun. 15, 2022 USD ($) shares	Jun. 02, 2022 USD ($)	May 30, 2022 $ / shares shares	Apr. 06, 2022 USD ($) $ / shares shares	May 31, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Apr. 08, 2022 USD ($)	Dec. 31, 2021 $ / shares shares
Class of Stock [Line Items]
Preferred shares, shares authorized (in shares) | shares							2,000,000			2,000,000
Preferred shares, par value (in dollars per share) | $ / shares							$ 0.0001			$ 0.0001
Preferred shares, shares issued (in shares) | shares							15,000			0
Preferred shares, shares outstanding (in shares) | shares							15,000			0
Common shares, shares authorized (in shares) | shares							170,000,000			170,000,000
Common shares, par value (in dollars per share) | $ / shares							$ 0.0001			$ 0.0001
Common shares, shares outstanding (in shares) | shares							9,407,296			8,544,225
Common shares, shares issued (in shares) | shares							9,407,296			8,544,225
Proceeds from sale of equity, net			$ 14,900,000
Proceeds from the issuance of common stock			2,000,000				$ 15,016,000	$ 0
Proceeds from issuance of warrants			12,900,000
Stock issuance costs			100,000				$ 106,000	$ 0
PIPE Purchase Agreement Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares				9,900,990,000,000
Exercise price of warrant (in dollars per share) | $ / shares				$ 1.39
Warrant price (dollars per share) | $ / shares				$ 0.125
PIPE Purchase Agreement Pre-Funded Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares				1,267,897
Discount from stock price (dollars per share) | $ / shares				$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares				$ 0.0001
Registered Direct Offering Warrants
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares				7,788,480
Discount from stock price (dollars per share) | $ / shares				$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares				$ 0.0001
Ownership threshold				9.99%
Series X Convertible Preferred Stock
Class of Stock [Line Items]
Interest rate percentage					1.00%
Common stock trading price (per share) | $ / shares					$ 22.00
Common stock trading period					30 years
Conversion price (per share) | $ / shares					$ 11.00
Convertible preferred stock (in shares)					91
Outstanding common stock, percentage					9.90%
Outstanding common stock, not to exceed, percentage					19.90%
Percentage of investment owned					50.00%
Maximum working capital line					$ 5,000,000
Consideration received					15,000,000
Proceeds from sale of equity, net					14,900,000
Stock issuance costs					100,000
Da Vita Healthcare Partners Inc | Share Issuance, Tranche One
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock					7,500,000
Da Vita Healthcare Partners Inc | Share Issuance, Tranche Two
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock	$ 7,500,000	$ 7,500,000
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized					15,000,000
Sale of stock, capital proceeds threshold					$ 15,000,000
Common stock trading price (in dollars per share) | $ / shares					$ 1,000
Consideration received			$ 15,000,000
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Share Issuance, Tranche One
Class of Stock [Line Items]
Number of shares issued | shares					7,500
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Share Issuance, Tranche Two
Class of Stock [Line Items]
Number of shares issued | shares	7,500	7,500
Controlled Equity Offering | Cantor Fitzgerald & Co
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized									$ 12,200,000
Number of shares issued | shares						7,500
Consideration received						$ 15,135
Weighted-average selling price (dollars per share) | $ / shares						$ 2.02
Stock issuance costs						$ 378
Registered Direct Offering
Class of Stock [Line Items]
Number of shares issued | shares				844,613
Common stock trading price (in dollars per share) | $ / shares				$ 1.39
Registered Direct Offering | Registered Direct Offering Warrants
Class of Stock [Line Items]
Discount from stock price (dollars per share) | $ / shares				0.0001
Exercise price of warrant (in dollars per share) | $ / shares				$ 0.0001